Infinity Pharmaceuticals, Inc. Retained Earnings
Infinity Pharmaceuticals, Inc. had Retained Earnings of -$876.95 million as of 2023-06-30, per its 10-Q filed 2023-08-10.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2023-08-10
- 2023-06-30: Retained Earnings (Accumulated Deficit) -$876.95M.
- 2023-03-31: Retained Earnings (Accumulated Deficit) -$867.00M.
- 2022-12-31: Retained Earnings (Accumulated Deficit) -$855.95M.
- 2022-09-30: Retained Earnings (Accumulated Deficit) -$846.72M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2023-06-30 | -$876.95M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | -$867.00M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | -$855.95M 10-Q · filed 2023-08-10 | |
| 2022-09-30 | -$846.72M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | -$836.00M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | -$824.02M 10-Q · filed 2022-05-03 | |
| 2021-12-31 | -$811.58M 10-K · filed 2023-03-28 | |
| 2021-09-30 | -$799.93M 10-Q · filed 2021-11-02 | |
| 2021-06-30 | -$789.22M 10-Q · filed 2021-07-27 | |
| 2021-03-31 | -$777.95M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | -$766.32M 10-K · filed 2022-03-29 | |
| 2020-09-30 | -$755.72M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | -$746.19M 10-Q · filed 2020-07-30 | |
| 2020-03-31 | -$736.72M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | -$725.83M 10-K · filed 2021-03-16 | |
| 2019-09-30 | -$714.45M 10-Q · filed 2019-10-30 | |
| 2019-06-30 | -$703.03M 10-Q · filed 2019-07-30 | |
| 2019-03-31 | -$692.52M 10-Q · filed 2019-05-07 | |
| 2018-12-31 | -$678.77M 10-K · filed 2020-03-03 | |
| 2018-09-30 | -$670.55M 10-Q · filed 2018-11-05 | |
| 2018-06-30 | -$683.93M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | -$676.97M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | -$667.52M 10-K · filed 2019-03-14 | |
| 2017-09-30 | -$660.22M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | -$653.12M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | -$636.16M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | -$625.69M 10-K · filed 2018-03-15 | |
| 2016-09-30 | -$602.76M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | -$583.26M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | -$636.25M 10-Q · filed 2016-05-04 | |
| 2015-12-31 | -$595.59M 10-K · filed 2017-03-14 | |
| 2015-09-30 | -$556.40M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | -$598.94M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | -$560.51M 10-Q · filed 2015-05-06 | |
| 2014-12-31 | -$467.21M 10-K · filed 2016-02-23 | |
| 2014-09-30 | -$426.87M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | -$530.09M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | -$492.06M 10-Q · filed 2014-05-06 | |
| 2013-12-31 | -$449.80M 10-K · filed 2015-02-24 | |
| 2013-09-30 | -$416.87M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | -$382.93M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | -$350.34M 10-Q · filed 2013-05-07 | |
| 2012-12-31 | -$323.02M 10-K · filed 2014-02-25 | |
| 2012-09-30 | -$276.03M 10-Q · filed 2012-11-06 | |
| 2012-06-30 | -$294.43M 10-Q · filed 2012-08-07 | |
| 2012-03-31 | -$279.77M 10-Q · filed 2012-05-08 | |
| 2011-12-31 | -$269.05M 10-K · filed 2013-03-05 | -$269.05M 10-K · filed 2012-03-13 |
| 2011-09-30 | -$254.99M 10-Q · filed 2011-11-08 | |
| 2011-06-30 | -$243.05M 10-Q · filed 2011-08-09 | |
| 2010-12-31 | -$229.01M 10-K · filed 2012-03-13 |